Atarax and Revatio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atarax and Revatio. Common interactions include cholelithiasis among females and shock among males.

The phase IV clinical study analyzes what interactions people who take Atarax and Revatio have. It is created by eHealthMe based on reports of 81 people who take Atarax and Revatio from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

81 people who take Atarax and Revatio together, and have interactions are studied.


What is Atarax?

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 21,195 Atarax users for its effectiveness, alternative drugs and more.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 42,668 Revatio users for its effectiveness, alternative drugs and more.

Number of Atarax and Revatio reports submitted per year:

Atarax and Revatio drug interactions.

Common Atarax and Revatio drug interactions by gender *:

female:

  1. Cholelithiasis
  2. Epistaxis
  3. Haemorrhage intracranial
  4. Seizure
  5. Malaise
  6. Vomiting
  7. Gastrointestinal disorder
  8. Oxygen saturation decreased
  9. Rash
  10. Autoimmune hepatitis

male:

  1. Shock
  2. Hyperlactacidaemia
  3. Pain
  4. Pain in extremity
  5. Pain in jaw
  6. Plantar fasciitis
  7. Stomatitis
  8. Hepatic failure
  9. Nasopharyngitis
  10. Weight increased

Common Atarax and Revatio drug interactions by age *:

0-1:

  1. Hepatocellular injury
  2. Hyperpyrexia
  3. Pyrexia
  4. Rhabdomyolysis
  5. Haemorrhagic diathesis
  6. Platelet count decreased

2-9:

  1. Cerebral haemorrhage
  2. Cholelithiasis
  3. Haemorrhage intracranial
  4. Headache
  5. Pyrexia
  6. Seizure
  7. Upper respiratory tract infection
  8. Bradycardia
  9. Malaise

10-19:

n/a

20-29:

  1. Chronic respiratory failure
  2. Dyspnoea
  3. Fluid overload
  4. Lung transplant
  5. Respiratory syncytial virus infection
  6. Syncope
  7. Application site pain
  8. Cardiac failure
  9. Catheter site swelling
  10. Device related infection

30-39:

  1. Anaemia
  2. Thrombocytopenia
  3. Adrenal insufficiency
  4. Biliary colic
  5. Brain natriuretic peptide increased
  6. Chills
  7. Device related infection
  8. Disseminated intravascular coagulation
  9. Dyspnoea
  10. Fluid overload

40-49:

  1. Nausea
  2. Diarrhoea
  3. Pain in extremity
  4. Headache
  5. Pain
  6. Pain in jaw
  7. Plantar fasciitis
  8. Pneumonia
  9. Rash
  10. Stomatitis

50-59:

  1. Disease progression
  2. Haemoglobin decreased
  3. Rash
  4. Tachycardia
  5. Tricuspid valve incompetence
  6. Abdominal discomfort
  7. Abdominal pain
  8. Abdominal pain upper
  9. Acute myocardial infarction
  10. Alanine aminotransferase increased

60+:

  1. Weight fluctuation
  2. Thrombocytopenia
  3. Nausea
  4. Overdose
  5. Oxygen saturation decreased
  6. Rectal haemorrhage
  7. Dehydration
  8. Diverticulitis
  9. Malaise
  10. Death

Common conditions people have *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 41 people, 50.62%
  2. Depression: 13 people, 16.05%
  3. Type 2 Diabetes: 10 people, 12.35%
  4. Nausea (feeling of having an urge to vomit): 9 people, 11.11%
  5. Diarrhea: 9 people, 11.11%
  6. Rashes (redness): 8 people, 9.88%
  7. Hiv Infection: 8 people, 9.88%
  8. Itching: 7 people, 8.64%
  9. Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 6 people, 7.41%
  10. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Atarax and Revatio?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atarax and Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atarax interactions:

Browse all interactions between Atarax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Revatio interactions:

Browse all interactions between Revatio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and sildenafil citrate (the active ingredients of Atarax and Revatio, respectively), and Atarax and Revatio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: